M.A. Argiriadi
74 works · 1,910 citations · h-index 18
Top works
- In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)
- Detoxification of environmental mutagens and carcinogens: Structure, mechanism, and evolution of liver epoxide hydrolase
- Binding of Alkylurea Inhibitors to Epoxide Hydrolase Implicates Active Site Tyrosines in Substrate Activation
- Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages
- Discovery of thieno[2,3-c]pyridines as potent COT inhibitors
- Biochemical Evidence for the Involvement of Tyrosine in Epoxide Activation during the Catalytic Cycle of Epoxide Hydrolase
- THU0127 Pharmacodynamics of A Novel JAK1 Selective Inhibitor in Rat Arthritis and Anemia Models and in Healthy Human Subjects
- Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol
- Discovery and Characterization of Non-ATP Site Inhibitors of the Mitogen Activated Protein (MAP) Kinases
- Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis
- Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitors
- Discovery of Selective and Orally Bioavailable Protein Kinase Cθ (PKCθ) Inhibitors from a Fragment Hit
- Covalent binders in drug discovery
- Crystal structure of a DNA polymerase sliding clamp from a Gram-positive bacterium
- Optimized Protein Kinase Cθ (PKCθ) Inhibitors Reveal Only Modest Anti-inflammatory Efficacy in a Rodent Model of Arthritis
- Unusual Water-mediated Antigenic Recognition of the Proinflammatory Cytokine Interleukin-18
- 2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization
- 2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode
- CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
- Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor